Article Text

Download PDFPDF
Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing
  1. Shuai Yang1,
  2. Ruixia Song1,
  3. Junmei Zhang2,
  4. Xiaohui Li1,
  5. Caifeng Li2
  1. 1 Department of Cardiovascular Diseases, Children’s Hospital Capital Institute of Pediatrics, Beijing, China
  2. 2 Department of Rheumatology and Immunology, Beijing Children’s Hospital, Capital Medical University, Beijing, China
  1. Correspondence to Dr. Xiaohui Li, Department of Cardiovascular Diseases, Children’s Hospital Capital Institute of Pediatrics, Beijing 100020, China; lxhmaggie{at}126.com and Dr. Caifeng Li, Department of Rheumatology and Immunology, Beijing Children’s Hospital, Capital Medical University, Beijing 100020, China; caifeng_li{at}yeah.net

Footnotes

  • SY and JZ contributed equally.

  • Contributors XL and CL designed the study. SY and JZ collected and analysed the data. RS drafted the manuscript and SY revised the paper. XL and CL contributed to the interpretation of the results and critical revision of the manuscript.

  • Funding This work was supported by the Science Foundation for Clinical Technical Innovation Project of the Beijing Municipal Administration of Hospitals (XMLX201612). The funder had no role in this study.

  • Competing interests None declared.

  • Patient consent Parental/guardian consent obtained.

  • Ethics approval All procedures regarding this work comply with the ethical standards of the relevant national guidelines on human experimentation and with the Declaration of Helsinki, as revised in 2008. The study was approved by the Ethics Committee of the Capital Institute of Pediatrics (no 2015040).

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • SY and JZ contributed equally.

  • Contributors XL and CL designed the study. SY and JZ collected and analysed the data. RS drafted the manuscript and SY revised the paper. XL and CL contributed to the interpretation of the results and critical revision of the manuscript.

  • Funding This work was supported by the Science Foundation for Clinical Technical Innovation Project of the Beijing Municipal Administration of Hospitals (XMLX201612). The funder had no role in this study.

  • Competing interests None declared.

  • Patient consent Parental/guardian consent obtained.

  • Ethics approval All procedures regarding this work comply with the ethical standards of the relevant national guidelines on human experimentation and with the Declaration of Helsinki, as revised in 2008. The study was approved by the Ethics Committee of the Capital Institute of Pediatrics (no 2015040).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.